Project Details
| Short title | A Phase 1b Study of Eltromobopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders (ELAstic) |
|---|---|
| Status | Finished |
| Effective start/end date | 1/10/14 → 30/09/21 |
Funding
- Glaxosmithkline
- CELGENE INTERNATIONAL SARL